Navigation Links
Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
Date:11/13/2012

Mountain View, California; November 13, 2012. Edison Pharmaceuticals today announced the initiation of a phase 2B study entitled, "A Phase 2B Randomized, Placebo-Controlled, Double-Blind Clinical Trial of EPI-743 in Children with Leigh Syndrome." Four clinical trial sites have been selected in the United States: Lucile Packard Children's Hospital, Stanford University Medical Center Palo Alto, California; Akron Children's Hospital Akron, Ohio; Seattle Children's Hospital Seattle, Washington; and Texas Children's Hospital, Baylor University Houston, Texas.

The trial is a placebo-controlled study lasting six months, and then extending an additional six months, during which all subjects will receive EPI-743. Subjects must be between one and twelve years old, possess genetic confirmation of Leigh syndrome, and meet certain disease severity criteria. More information on the study specifics is available on ClinicalTrials.gov.

The primary endpoint of the clinical trial is the Newcastle Paediatric Mitochondrial Disease Scale. Secondary endpoints include neurologic, muscular, imaging, and biomarker indices. The study design was based on positive phase 2A data recently reported in the journal Molecular Genetics and Metabolism, "EPI-743 reverses the progression of the pediatric mitochondrial disease- genetically defined Leigh Syndrome" 107 (2012) 383-388.


'/>"/>

Contact: Lorraine Gilmore
Lgilmore@edisonpharma.com
650-641-9202
Edison Pharmaceuticals, Inc.
Source:Eurekalert

Page: 1

Related medicine news :

1. Environmentally friendly chemistry important for manufacturing pharmaceuticals
2. Scientists use sound waves to levitate liquids, improve pharmaceuticals
3. Plastic and Reconstructive Surgery Journal announces global expansion initiatives
4. NY-Presbyterian Hospital announces participation in trial for hard-to-treat hypertension
5. Northeasterns Barnett Institute announces formation of leading analytics company, BioAnalytix, LLC
6. JDRF announces winners of first phase of Agnes Varis Glucose-Responsive Insulin Challenge
7. CRF announces late breaking trials and first report investigations to be presented at TCT 2012
8. SfN announces winners of brain awareness video contest
9. COPD Foundation and BWH announces second phase of groundbreaking COPDGene project
10. NYU School of Medicine announces new clinical trial for ulcerative colitis
11. ASTRO announces 2012 fellows class
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... Fla. (PRWEB) , ... May 02, 2016 , ... ... fat,” wraps itself around major organs, such as the kidneys, liver and pancreas. ... Robert Drapkin, M.D ., a board-certified physician in Internal Medicine, Medical Oncology and ...
(Date:5/2/2016)... ... , ... Pregnancy Awareness Month offers a great time to get familiar with ... are ready to have a baby, it’s best to get started before age becomes ... Personal Conception & Pregnancy Organizer, written for women who plan on becoming pregnant to ...
(Date:5/2/2016)... ... 2016 , ... Consultative health care market research firm ... Duane Reed, VP of business development of AJMC Strategic Solutions, will be session ... General Meeting from May 15-17 at the Boca Raton Resort & Club ...
(Date:5/2/2016)... Greifensee, Switzerland (PRWEB) , ... May 02, 2016 , ... ... Visual and performance artist Curt Walter has developed it into a science. , ... has helped Walter achieve subtly differentiated shades that add depth and meaning to his ...
(Date:5/2/2016)... ... May 02, 2016 , ... Summit BHC (Summit), a ... of Twin Lakes Recovery Center. Located east of Atlanta in Monroe, Georgia, ... The residential facility is set on 34 acres of beautiful, secluded property that ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... le 27 Avril 2016 ... progressé de +5% sur le trimestre, soutenu par ... consommables  Croissance de +16% des ventes ... Mauna Kea Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : ... laser, annonce aujourd,hui son chiffre d,affaires pour le ...
(Date:4/27/2016)... NORWALK, Conn. , April 27, 2016 /PRNewswire/ ... availability of its digital health technology platform, which ... services and programs into scalable digital products, Zillion ... mobile engagement and empower consumers to take control ... features face-to-face live video conferencing – including one-to-one, ...
(Date:4/27/2016)... , April 27, 2016 ... of the  "Global Anesthesia Disposables Market 2016-2020" ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ,The global anesthesia disposables ... CAGR of 4.03% during the period 2016-2020.  ... major threat to patients, safety. Organizations like ...
Breaking Medicine Technology: